Investing for the long termIf you've got it, don't flaunt itJoin the NASDAQ Community today and get free, instant access to portfolios, stock ratings, real-time alerts, and more! (RTTNews.com) - Regeneron Pharmaceuticals, Inc. ( REGN ) and Decibel Therapeutics, Inc. announced a collaboration to discover new potential therapeutics to protect, repair, and restore hearing. Regeneron will provide Decibel with broad access to its suite of technologies. The company will also directly participate in and provide financial support for Decibel's research and development efforts, both through R&D funding payments and a strategic equity investment in Decibel.Decibel retains worldwide development and commercialization rights to any products discovered in the collaboration and will pay Regeneron tiered royalties based on net sales.For comments and feedback: contact editorial@rttnews.comEnter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
					You have selected to change your default setting for the Quote Search. This will now be your default target page;
					unless you change your configuration again, or you delete your
					cookies. Are you sure you want to change your settings?
Please disable your ad blocker (or update your settings to ensure that javascript and cookies are enabled), so that we can continue to provide you with the first-rate market news and data you've come to expect from us.